Prostate cancer when it occurs to a certain extent is prone to bone metastases, usually in the spine, pelvis, ribs and proximal long bones, with metastases to the medial bones being the most common, that is, the spine is more common.
Bone metastases from prostate cancer, which generally coexist with osteogenic and osteolytic lesions, can be diagnosed by examination. Even if bone metastases are present, treatment should not be abandoned, with the main goal of improving symptoms and quality of life.
For patients who present with spinal metastases and do not have spinal cord compression but do not have symptoms of paralysis, endocrine therapy is recommended along with radiation therapy for the bone lesion. In contrast, for patients who develop pathologic fractures, spinal cord compression, and impaired neurologic function, surgical spinal incision and decompression, lesion removal, and internal fixation surgery may be considered.
Patients with bone metastases from prostate cancer are determined by multiple factors and should be treated aggressively and effectively, and should not be given up blindly. Most patients with aggressive treatment can live significantly longer, for example, 2 years, or even about 5 years.